International Journal of Head and Neck Surgery

Register      Login

VOLUME 3 , ISSUE 2 ( May-August, 2012 ) > List of Articles


Comparative Study of Intralesional Triamcinolone Acetonide and Hyaluronidase vs Placental Extract in 60 Cases of Oral Submucous Fibrosis

Sudhir Naik, S Ravishankara, Mohan K Appaji, MK Goutham, Nonthombam Pinky Devi, Annapurna S Mushannavar

Citation Information : Naik S, Ravishankara S, Appaji MK, Goutham M, Devi NP, Mushannavar AS. Comparative Study of Intralesional Triamcinolone Acetonide and Hyaluronidase vs Placental Extract in 60 Cases of Oral Submucous Fibrosis. Int J Head Neck Surg 2012; 3 (2):59-65.

DOI: 10.5005/jp-journals-10001-1096

Published Online: 01-05-2013

Copyright Statement:  Copyright © 2012; The Author(s).



Oral submucous fibrosis (OSMF) is a common premalignant condition caused by chewing arecanut, betel quid and gutkha with tobacco. Its medical treatment is not yet fully standardized, although the optimal doses of its medical treatment is in the form of triamcinolone acetonide combined with hyaluronidase or intralesional placental extract.


We compared the efficacy of intralesional triamcinolone acetonide combined with hyaluronidase in group A vs placental extract in group B.


Comparative case series analysis series study with random allocation of 60 patients equally into two groups.

Materials and methods

Patients of OSMF (60) were randomly allocated into two groups A and B. Group A (n = 30) patients received combination of triamcinolone acetonide (10 mg/ml) + hyaluronidase (1,500 IU) at weekly intervals for 8 weeks. Group B (n = 30) patients received 2 ml of placentrex injection intralesionally at weekly interval for 8 weeks. Treatment outcome was evaluated on the basis of improvement in trismus, oral mucosal pattern and reduction in burning sensation.


Trismus improvements in group A with combination of triamcinolone acetonide + hyaluronidase were significantly better to that in group B where placentrex was used. No significant difference in results in the two groups were observed as far as improvement in oral mucosal pattern and burning sensation were compared in the two groups.


Combination of triamcinolone acetonide and hyaluronidase intralesionally is more effective than placental extract intralesionally in treatment of OSMF. But placental extract injections are cost-effective. No side effects were seen in both study groups.

How to cite this article

Naik SM, Appaji MK, Ravishankara S, Goutham MK, Devi NP, Mushannavar AS, Naik SS. Comparative Study of Intralesional Triamcinolone Acetonide and Hyaluronidase vs Placental Extract in 60 Cases of Oral Submucous Fibrosis. Int J Head Neck Surg 2012;3(2):59-65.

PDF Share
  1. Frequency of oral submucous fibrosis among 100 South Indian with oral cancer. Bull WHO 1965;32:750-53.
  2. Clinical aspects of OSMF. Acta Odont Scand 1964;22:679-81.
  3. OSMF in a 4 years child. Oral Surg 1985;59: 475-78.
  4. Oral submucous fibrosis (OSMF). Indian J Dermatol Venereol Leprol 2000;66(5):255-56.
  5. Submucous fibrosis of palate and pillars. Ind J Otolaryngol 1953;4:1-4.
  6. The effects of placenta extract in management of oral submucous fibrosis. Indian J Pharmacol 1992;24:181-83.
  7. Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of OSMF: Indian J Med Res 2010 May;131:665-69.
  8. Oral submucous fibrosis clinical study and management by physiofibrolysis (MWB). J Ind Dent Asso 1980;52:375-78.
  9. The effects of collagenase and oral submucous fibrosis. J Ind Dent Asso 1980;52:243-46.
  10. The etiology of oral submucous fibrosis: The stimulation of collagen synthesis by extracts of areca nut. Int J Oral Surg 1981;10:163-67.
  11. The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol 2007;43(7): 680-85.
  12. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 2002 Feb;38(2):195-200.
  13. The upregulation of insulinlike growth factor-1 in oral submucous fibrosis. Oral Oncol 2005 Oct;41(9):940-46.
  14. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Oral Dis 2004 Nov;10(6):360-64.
  15. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 1986;31(1):45-49.
  16. Oral submucous fibrosis: An unusual disease. JNJ Dent Assoc. Spring 1997;68(2):17-19.
  17. The areca nut chewing habit and oral squamous cell carcinoma in South African-Indians. A retrospective study. S Afr Med J 1993 Jun;83(6):425-29.
  18. Elevated expression of NF-kappa B in oral submucous fibrosis - Evidence for NF-kappa B induction by safrole in human buccal mucosal fibroblasts. Oral Oncol 2006 Sep;21.
  19. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med 2000 Jul;29(6):241-48.
  20. Oral submucous fibrosis: A review. 4. Ann Acad Med Surg 1989;18:603-07.
  21. Histological changes in palatal and paratubal muscles in oral submucous fibrosis. MS thesis, University of Allahabad; 1999.
  22. To study the Eustachian tube function in patients of oral submucousfibrosis. MS thesis, University of Allahabad; 2003.
  23. Efficacy of lycopene in the management of OSMF. Or Sur Or Med 2007;103;207-13.
  24. Pentoxyphyline therapy; a new adjunct in the treatment of OSMF. Indian J Dent Res 2006:17:190-98.
  25. Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 1978; 30:103.
  26. Collagenase: Preparation, properties, action and uses: A review of literature. J Indian Dent Assoc 1980;52: 353-54.
  27. Oral submucous fibrosis treatment with hyalase. J Laryngol Otol 1985;99: 57-59.
  28. Intraoral injection of hydrocortisone and hyaluronidase in oral submucous fibrosis. Indian Prac 1990;575-80.
  29. Management of oral submucous fibrosis: A conservative approach. J Oral Maxillofac Surg 1991;49: 788-91.
  30. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 1995;24:402-06.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.